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Abstract
The empirical methodology used by Persson and Rossin-Slater (2016) to estimate
the causal effect of in utero exposure to stress on later outcomes has two sources of bias.
First, they define the control group in such a way that biases their causal estimates and
can lead to the finding of a significant relationship when there is none. Therefore, the
causal effect that the authors claim to establish may in fact be spurious correlation from
an error in their empirical methodology. Second, measurement error in the estimation
of gestation age can exacerbate the magnitude of the bias caused by the misspecified
control group. An additional concern is that the endogeneity of actual birth date may
make little practical difference in this context, which undermines the author’s claim of
being the first to establish a causal effect.
1 Introduction
In their paper “Family Ruptures, Stress, and the Mental Health of the Next Generation”,
Persson and Rossin-Slater attempt to estimate the causal effect of in utero exposure to
†Contact: matsumoto.brett@bls.gov. This version primarily focuses on criticisms not contained in the first
version of the comment. It should therefore be viewed as an extension of the earlier version, although some
portions of the earlier comment are included for the sake of completeness. Prior to writing this comment, I
posted an outline of the criticisms contained in this document in various online forums. I can certify that
I am the author of the relevant posts and that the ideas put forth here are my own. I would particularly
like to acknowledge the support of anonymous economists at econjobrumors.com who played a critical role
in helping me to formulate the ideas contained within this note.
‡The views and opinions expressed in this paper are my own and do not reflect the views of the BLS,
Department of Labor, or the Federal Government.
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stress and mental health outcomes later in life. They do this by considering mothers who
experience the loss of a close relative during pregnancy as the treatment group. The control
group is mothers who experience this loss shortly after birth. Let c denote conception, b
denote birth, and eb denote expected date of birth (eb = c + 280 days). Then the authors
estimate the causal effect using the following equation (equation 5 in the paper):
Outcome = β0 + β11[c ≤ RelativeDeath < eb] + , (1)
where the estimation sample is limited to mothers who experience the relative death during
pregnancy or within one year of actual birth. The concern with defining the treatment
variable as the relative death occurring prior to the actual date of birth is that the actual
date of birth may be correlated with the error term. On the one hand, there is the mechanical
relationship that a relative death is more likely to occur during pregnancy the longer the
pregnancy lasts. Also, there is the concern that the treatment defined using actual date of
birth is endogenous since relative death can affect the length of the pregnancy. The authors
claim that defining the treatment group based on the expected date of birth corrects for the
endogeneity. Alternatively, the causal parameter could be estimated using treatment based
on expected date of birth as an instrument for treatment based on actual date of birth.
This identification strategy suffers from two sources of bias. First, defining the control
group using deaths that occur one year from the actual date of birth creates spurious cor-
relation that biases the causal estimates. Second, measurement error in gestation age can
bias the results, particularly for outcomes that are defined in terms of actual gestation age.
Finally, even if the control group is defined correctly and measurement error is small, endo-
geneity of actual date of birth may make little practical difference in this context. The next
few sections describe these issues in greater detail and provide simulation evidence that the
empirical methodology of Persson and Rossin-Slater (2016) is flawed and that their results
are biased.1
2 Misspecified Control Group
The control group is defined implicitly through the sample restriction and includes mothers
who experience the death of a relative between the expected date of birth and one year after
the actual date of birth. The correct specification uses the expected date of birth to define all
1Black et al. (2016) use a similar identification strategy but also include mother fixed effects. Some of
the issues raised in this comment also apply to Black et al. (2016), but the main concern of bias due to
misspecification of the control group does not apply. Also, a variation of this identification strategy was also
used by Currie and Rossin-Slater (2013); Rossin-Slater (2013) and some of the issues raised here apply to
those papers as well.
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of the treatment and control thresholds. By defining the end of the control group as one year
after actual birth, the length of the period that defines the control group differs depending
on when a child is born relative to the expected birth date. For the treatment effect (β1) to
be unbiased, not only does there have to be no selection into treatment, there also has to not
be selection into the control group (since the treatment effect is defined as the conditional
(on observables) difference in mean outcome between the control and the treatment group).
The probability that someone is control (versus out of the sample) depends on the length
of the control group interval (eb to b + 365). Since individuals who are born prematurely
(b < eb) have a shorter control group window, these individuals are less likely to be in the
control group. For any outcome correlated with actual gestation length, the average outcome
of the control group will be skewed towards individuals with high gestation length. Since
the average outcome of the control group is biased, the treatment effect is biased in the
opposite direction. For example, consider the case where the average gestation length is the
same for all groups. The average for the treatment group is equal to the true population
average, but the average for the control group will be higher because individuals with longer
actual gestation lengths are overrepresented in the estimation sample. From this, one would
falsely conclude that the treatment effect on gestation length is negative. Virtually all of the
outcomes considered are correlated to some degree with actual gestation length (e.g., birth
weight, health conditions at birth or shortly after, and even later life outcomes), which means
that the misspecification of the control group causes bias in all of the results. The direction
of the bias is in the direction of the estimated results, so the authors cannot conclude that
their significant results are due to there actually being a true causal effect rather than just
the result of careless empirical work.2
3 Measurement Error in Gestation Age
The second concern is related to the use of gestation age to generate the exogenous treatment
variable based on the expected date of birth. The expected date of birth is defined as the
date of conception plus 280 days. The problem is that the date of conception is not known,
so the authors calculate it using the gestation age, which is reported in the data. Gestation
age is itself merely an estimate, so the conception date as calculated is measured with error.3
2See Black et al. (2016) for an example of this identification strategy that uses a correctly specified control
group.
3The initial estimate of conception date is 14 days after the start of the last menstrual cycle. This estimate
is later refined based on prenatal ultrasounds. If the estimated gestational age based on the ultrasound is
significantly different from that based on the last menstrual cycle, then the ultrasound estimate is used as the
preferred measure (see American College of Obstetricians and Gynecologists (2014) for details). Significantly,
the accuracy of the estimate of gestational age based on ultrasound decreases as the pregnancy progresses.
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The authors do not provide any detail in their paper about how the gestation age is
measured but have informed me that the measure used is based on the last menstrual cycle.
The estimate based on last menstrual cycle will have greater measurement error than alter-
native measures, but the magnitude of the error will be equal for the treatment and control
groups. There is a problem when this identification strategy is used for outcomes that are
defined based on gestation age. This is because the error in measuring gestation age will
occur in both the LHS outcome variable and in the RHS definition of the treatment vari-
able. Measurement error in the LHS variable will be captured in the error term. Therefore,
the measurement error in gestation age will cause the error term to be correlated with the
treatment variable and will bias the estimate of the causal effect of the treatment. With a
properly specified control group, the measurement error does not appear to create much bias
in the results.4 When the control group is misspecified, however, the measurement error will
increase the bias.5 The amount of additional bias depends on the variance of the measure-
ment error. I provide simulation evidence that the effect of both the misspecified control
group and measurement error in gestation age cause bias in the empirical specification of
Persson and Rossin-Slater (2016). Specifically, the simulation evidence shows that one can
obtain a statistically significant estimate of the treatment effect in the direction of the results
reported in their paper when the true effect is zero.
4 Endogeneity of Actual Date of Birth
An additional concern with the identification strategy is that the endogeneity of defining
treatment using the actual date of birth may make little practical difference. In Persson and
Rossin-Slater (2016) the endogeneity of actual date of birth may not generate much bias
in the OLS estimate based on the results of the first stage regression (R2 of approximately
The most accurate estimate of gestational age is obtained from an ultrasound at between 10-12 weeks. By
the 24 week mark, the estimate based on the ultrasound is no more precise than that based on last menstrual
cycle (Verburg et al., 2008). The estimate of gestation age based on ultrasound will be more precise, but the
treatment may affect how individuals time their prenatal care. In order to use the estimate of gestation age
based on ultrasound, researchers will have to show that the treatment is unlikely to affect the estimate of
gestation age as individuals in the treatment group may delay or skip prenatal appointments if they coincide
with the treatment (e.g., death of a close relative, hurricane, etc.). Particularly if these missed appointments
are early in the pregnancy, the treatment group may have poorly estimated gestation ages relative to the
control group.
4This finding is based on the results of a few relatively simple simulations. Anyone wishing to use this
identification strategy should perform additional analysis to determine if measurement error with a properly
specified control group is likely to affect their results.
5This is because the measurement error in gestation age affects all of the thresholds equally, except the
endpoint of the control group. Since the measurement error affects the control group differently than the
treatment group, the estimate of the treatment effect (which is the difference) will be biased.
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0.97, Table D-1) and the statement that “the instrument (relative death before expected
birth date) is different from the actual exposure variable (relative death before actual birth
date) for only about 1 percent of the individuals in our data.”
In a related paper Black et al. (2016), present the results using the same identification
strategy on different data and outcomes. They report that the first stage R2 is very close to
one and that the OLS estimates and the 2SLS estimates are very similar when considering
later in life outcomes, but they do find differences when considering birth outcomes.6 None
of the studies that use expected date of birth to instrument for actual date of birth conduct
statistical tests for endogeneity of actual date of birth for the various outcomes.
The problem for the authors is that they differentiate their results from a vast prior
literature that does not control for this endogeneity. Since they do not perform any statistical
tests for endogeneity and do not even report the OLS coefficients using actual date of birth
to define the treatment, it is impossible for the reader to evaluate whether endogeneity is a
significant problem in this context. If endogeneity is not a problem, then instead of being the
first to estimate the causal relationship, the authors are merely verifying that prior estimates
in the literature have a causal interpretation.
5 Simulation Results
The purpose of this simulation is to show that the issue of a misspecified control group
and measurement error in gestation age can cause the identification strategy of Persson
and Rossin-Slater (2016) to falsely attribute a significant causal effect to death in utero.
Conception occurs for all individuals at a given period C. The average pregnancy lasts 40
periods.7 Let φ denote a draw from a standard normal distribution, then birth occurs at
B = C+40+σBφ, where σ
2
B is the variance of the distribution of births. True gestation age at
birth is GA = B−C. The estimate of gestation age at birth is given by GˆA = B−C+σGAφ,
where the accuracy of the estimate is determined by σGA. Then, the estimated date of
conception is Cˆ = B − GˆA.
Deaths occur once for each individual and are distributed uniformly over the interval 0 to
T . The treatment group is defined as the death occurring in the interval between Cˆ and the
predicted date of birth, Cˆ+40. The control group is implicitly defined as the death occurring
between B and B+ 50 by limiting the estimation sample to anyone who experiences a death
6Other studies, such as Currie and Rossin-Slater (2013) and Rossin-Slater (2013), in different contexts
but still looking at in utero effects of some treatment find that instrumenting for treatment based on actual
date of birth using expected date of birth does yield different results. Those studies instrument for not only
the endogeneity of pregnancy length but also location change. This yields a lower first stage R2.
7A period can be thought of corresponding to one week.
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between Cˆ and B + 50. The simulations consider 4 different outcomes. The first two are
gestation age at birth and the probability of preterm birth (gestation age at birth less than
37). These outcomes have the gestation age measurement error in both the RHS definition
of the treatment group and the LHS outcome variable. The last 2 outcomes are correlated
with actual gestation age and differ by the amount of correlation. One outcome (Out 1) is
strongly correlated with actual gestation age and can be thought of as birth outcomes such
as birth weight, health conditions at birth, or birth complications. The other outcome (Out
2) is correlated with the first causing it to be more weakly correlated with actual gestation
age. Since birth weight is associated with many later in life outcomes, this second outcome
can be thought of corresponding to later in life outcomes.
The only explanatory variables are an intercept term and an indicator for treatment
(death between Cˆ and Cˆ + 40). For comparison, the results are also shown defining the
treatment using the actual date of conception C. These results allow the bias to be de-
composed between the spurious correlation caused by measurement error and the spurious
correlation caused by the misspecified control group. The simulations differ in the variance
of the error of the estimate of gestation age and the sample size with 1000 iterations used for
each combination of these parameters. The actual gestation age is used in the case where
the variance of the error in gestation age equals 0.
The following values are used in the simulation: C = 20, σB = 2, T = 130, Out1 =
.2 ∗ GA + φ, Out2 = −.25 ∗ Out1 + φ, where each φ is a draw from a standard normal
distribution.
As the sample size increases, the standard deviation of the estimates fall while the point
estimates are roughly the same. Therefore, the result of increasing the sample size is an
increase in the statistical significance of the treatment on all of the outcomes. As the error
in the measure of gestation age increases, the bias in estimating the effect on gestation age
related outcomes increases. This implies that noisier estimates of gestation age such as date
of last menstrual cycle will be more biased than estimates based on more accurate methods
such as ultrasound. Another important fact is that the direction of the bias is negative in
terms of total gestation length. Therefore, the significant negative findings in the literature
of a significant negative effect of in utero relative death on total gestation length may be
due to measurement error rather than reflecting a true causal relationship. Additionally,
even if gestation age was measured perfectly, the estimates are still biased based on how
the treatment and control groups are defined. The differences in the results of Persson and
Rossin-Slater (2016) and Black et al. (2016) are due, at least in part, to differences in how
the control groups are defined.
For the outcomes that are correlated with gestation age at birth, the bias does not
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Table 1 : Simulation Results
σGA
Outcome 0.0 0.5 1.0 1.5 2.0
N=10,000
GA -0.082 (0.049) -0.087 (0.051) -0.102 (0.055) -0.127 (0.058) -0.162 (0.065)
Pre-term 0.005 (0.006) 0.006 (0.006) 0.007 (0.006) 0.010 (0.007) 0.013 (0.009)
Out 1 -0.017 (0.026) -0.017 (0.026) -0.017 (0.026) -0.017 (0.026) -0.017 (0.026)
Out 2 0.005 (0.009) 0.005 (0.009) 0.005 (0.009) 0.004 (0.010) 0.004 (0.010)
N=100,000
GA -0.082 (0.015) -0.085 (0.016) -0.101 (0.017) -0.126 (0.019) -0.160 (0.021)
Pre-term 0.005 (0.002) 0.006 (0.002) 0.007 (0.002) 0.010 (0.002) 0.013 (0.003)
Out 1 -0.016 (0.009) -0.016 (0.009) -0.016 (0.009) -0.016 (0.009) -0.016 (0.009)
Out 2 0.004 (0.003) 0.004 (0.003) 0.004 (0.003) 0.004 (0.003) 0.004 (0.003)
N=1,000,000
GA -0.080 (0.005) -0.085 (0.005) -0.100 (0.005) -0.125 (0.006) -0.160 (0.007)
Pre-term 0.005 (0.001) 0.006 (0.001) 0.007 (0.001) 0.010 (0.001) 0.013 (0.001)
Out 1 -0.016 (0.003) -0.016 (0.003) -0.016 (0.003) -0.016 (0.003) -0.016 (0.003)
Out 2 0.004 (0.001) 0.004 (0.001) 0.004 (0.001) 0.004 (0.001) 0.004 (0.001)
Notes: Standard deviation in parenthesis. Average over 1,000 iterations.
appear to depend on how accurately gestation ages are measured. The source of the bias is
essentially entirely due to the definition of the control group. The next set of simulations
further examines this source of bias by looking at Out1 = GA ∗ .2 + ρ ∗ φ. For these
simulations, the variance in the gestation age measure is set at 1 and the correlation of Out
1 with actual gestation age is varied by changing ρ. The magnitude of the bias does not
change very much as the sample size increases or as the outcome becomes less correlated with
the actual gestation age. The significance of the estimated effect decreases as the variance
of the independent variation in the outcome increases. The bottom panel of the table shows
the results when the predicted date of birth is used to define the control group (death within
one year of the predicted date of birth). For these results the bias disappears.
These simulations show defining the control group using one year from the actual date
of birth causes bias for any outcome that is correlated with the actual gestation age at
birth. Measurement error of gestation age causes additional bias for outcomes that are
defined in terms of gestation age at birth. The misspecification of the control group creates
spurious correlation that bias nearly all of the estimates reported by Persson and Rossin-
Slater (2016). As long as this source of bias remains, there is no way to determine if the
statistically significant relationships they find are true causal relationships or merely the
result of their erroneous empirical specification.
7
Table 2 : Additional Simulation Results
ρ
Outcome 0.1 0.5 1.0 2.0
N=10,000
Out 1 -0.016 (0.010) -0.016 (0.016) -0.016 (0.026) -0.018 (0.049)
N=100,000
Out 1 -0.016 (0.003) -0.016 (0.005) -0.016 (0.008) -0.016 (0.015)
N=1,000,000
Out 1 -0.016 (0.001) -0.016 (0.002) -0.016 (0.003) -0.016 (0.005)
Treatment defined using predicted birth
N=100,000
Out 1 1.0e-4 (0.003) 1.0e-4 (0.005) 0.000 (.008) 7.0e-4 (0.016)
Note: Standard deviation in parenthesis. Average over 1000 iterations.
6 Conclusion
In light of the evidence presented in this comment, the authors and future researchers should
take additional steps to address these issues. For researchers who wish to use this identifi-
cation strategy in their own work I recommend (in addition to specifying the control group
correctly) that they report more detail on how gestation age is measured and consider the
effect that measurement error may have on their results. Additionally, given that treatment
based on expected date of birth almost perfectly coincides with treatment based on actual
date of birth, researchers should conduct statistical tests for endogeneity. At a minimum,
researchers should report the results for treatment defined both ways.
Persson and Rossin-Slater (2016) claim as their primary contribution that they are the
first to estimate a causal relationship between in utero exposure to stress and later in life
mental health outcomes. There are two problems with this claim. First, if endogeneity of
actual date of birth is not important when considering later in life mental health outcomes,
then the correlations from the prior medical literature have a causal interpretation. There-
fore, the authors are not the first to estimate a causal relationship. A simple statistical test
for endogeneity could resolve this issue. The second problem is that the estimates from their
empirical specification contain bias from their incorrectly specified control group, which is
compounded by measurement error in their estimate of gestation age. Luckily for the au-
thors, this issue is also easily addressable. All they need to do is to rerun their analysis
with the correctly specified control group. The authors have informed me that their article
is final and refuse to perform this very simple additional analysis. They are content to leave
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in doubt the primary contribution of their paper. What ever happened to taking pride in
ones work?
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